Mexico demands Boehringer Ingelheim/Sanofi animal health divestitures
European drugmakers Boehringer Ingelheim and Sanofi will have to sell five animal health vaccines to an approved third-party purchaser in Mexico to clear one of the few remaining antitrust hurdles facing the US$24.5 billion asset swap.
To read more
Subscribe to Latin Lawyer
Subscribe and start reading now
Latin Lawyer is your definitive source of news, analysis, and research from the Latin American legal community. It keeps you up to speed with the issues and trends that matter and provides the data and tools you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10